𝗪𝗵𝗮𝘁 𝗗𝗼𝗲𝘀 𝟮𝟬𝟮𝟱 𝗛𝗼𝗹𝗱 𝗙𝗼𝗿 𝗕𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮? - 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗮𝗻𝗱 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀
1
minutes
Full article published in: Citeline
BioLizard Welcomes Arjan van Manen as Commercial Director
5
minutes
Arjan van Manen joins BioLizard as Commercial Director, bringing over 20 years of commercial leadership experience in life sciences Meet BioLizard’s Arjan van Manen and CEO Liesbeth Ceelen at Biotech Showcase during JP Morgan Week (Jan 13-15, 2025) in San Francisco Discover Bio|Verse® Navigator, ...
BioLizard Launches Bio|Verse® Navigator for Easy Exploration of Complex Biomedical Data
4
minutes
Bio|Verse Navigator can accelerate data exploration and interpretation workflows multifold, reducing time-to-insight for researchers. The application combines advanced BioLizard’s bioinformatics expertise in handling various customer datasets with powerful visual analytics, capable of exploring ...
Transforming veterinary research using data science, one paw at a time
5
minutes
Data science is vastly changing the way we do research. Veterinary research is, however, still lagging behind its human counterpart. Why is this the case and can we learn from human health data to close this gap? Published by: BioVox on November 27, 2024 - link
Empowering data-driven decisions in drug discovery
5
minutes
Published by: European Biopharmaceutical Review on 23.10.2024. Link By Paul Vauterin, Chief Technology Officer at BioLizard In today’s life sciences industry, economic uncertainties are prompting a shift in investment focus. BioLizard addresses this challenge by empowering biotech companies to ...
Biomarker discovery 2.0: Using new technologies to access novel insights into human health and disease
5
minutes
Due to the size and dimensionality of the datasets required, data science is an essential component of modern biomarker discovery and development. It's no longer feasible to mine and process these data sets manually, which demands collaboration between R&D specialists, bioinformaticians, and ...
Beyond diagnostics: How biomarkers can be used to de-risk drug development
4
minutes
Biomarker discovery is important not only in the pursuit of better diagnostics but also for de-risking drug development. By leveraging validated biomarkers, you can prioritize drug candidates with higher likelihoods of therapeutic success, thereby reducing the risk of failure in later stages of ...